Delisting Determination,The Nasdaq Stock Market, LLC,
October 6, 2009, American Bio Medica Corp. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of American Bio Medica Corp.
(the Company), effective at the opening of the
trading session on October 16, 2009. Based on a review of
the information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for
listing on the Exchange pursuant to Listing Rule
5550(a)(2). The Company was notified
of the Staffs determination on August 25, 2009.
The Company did not appeal the Staff determination
to the Hearings Panel, and the Staff determination to
delist the Company became final on September 3, 2009.